![Lawrence Banks](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lawrence Banks
Chief Executive Officer at International Centre For Genetic Engineering & Biotechnology
Lawrence Banks active positions
Companies | Position | Start | End |
---|---|---|---|
International Centre For Genetic Engineering & Biotechnology
![]() International Centre For Genetic Engineering & Biotechnology Miscellaneous Commercial ServicesCommercial Services The International Centre for Genetic Engineering and Biotechnology is a research organization based in Trieste, Italy. The Italian company offers resources, tools, and know-how to fight the SARS-CoV-2 virus that causes COVID-19 to its member states free of charge. Additionally, the private company promotes international cooperation in developing and applying peaceful uses of genetic engineering and biotechnology, particularly for developing countries. The company's objective is to be the world's leading intergovernmental organization for research, training, and technology transfer in the field of life sciences and biotechnology. The company was founded in 1983, and Lawrence Banks has been the CEO since 2019. | Chief Executive Officer | 01/07/2019 | - |
Career history of Lawrence Banks
Statistics
International
Italy | 2 |
Operational
Chief Executive Officer | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
International Centre For Genetic Engineering & Biotechnology
![]() International Centre For Genetic Engineering & Biotechnology Miscellaneous Commercial ServicesCommercial Services The International Centre for Genetic Engineering and Biotechnology is a research organization based in Trieste, Italy. The Italian company offers resources, tools, and know-how to fight the SARS-CoV-2 virus that causes COVID-19 to its member states free of charge. Additionally, the private company promotes international cooperation in developing and applying peaceful uses of genetic engineering and biotechnology, particularly for developing countries. The company's objective is to be the world's leading intergovernmental organization for research, training, and technology transfer in the field of life sciences and biotechnology. The company was founded in 1983, and Lawrence Banks has been the CEO since 2019. | Commercial Services |
- Stock Market
- Insiders
- Lawrence Banks
- Experience